Viewing Study NCT05070260

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-25 @ 9:41 PM
Study NCT ID: NCT05070260
Status: COMPLETED
Last Update Posted: 2024-07-03
First Post: 2021-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo
Sponsor: Acticor Biotech
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Ischemic Stroke View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Haemorrhages GPVI View
None Thrombolysis View
None Thrombectomy View
None Anti-platelet View
None glenzocimab View
None ACT017 View
None stroke View
None GPVI View